Barbui, C, Gastaldon, C, Papola, D and Ostuzzi, G (2017 a) Antipsychotic drug exposure and risk of myocardial infarction. Epidemiology and Psychiatric Sciences 26, 18–21.
Barbui, C, Addis, A, Amato, L, Traversa, G and Garattini, S (2017 b) Can systematic reviews contribute to regulatory decisions? European Journal of Clinical Pharmacology 73, 507–509.
Papola, D, Ostuzzi, G, Thabane, L, Guyatt, G and Barbui, C (2018) Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies. International Clinical Psychopharmacology in press.
Solmi, M, Correll, CU, Carvalho, AF and Ioannidis, JP (2019) The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis. Epidemiology and Psychiatric Sciences in press.
Stone, M, Laughren, T, Jones, L, Levenson, M, Holland, PC, Hughes, A, Hammad, TA, Temple, R and Rochester, G (2009) Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339. doi: 10.1136/bmj.b2880.
Verdoux, H (2019) Safety of psychotropic medicines: contribution from observational evidence. Epidemiology and Psychiatric Sciences in press.